Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort
- PMID: 23374051
- DOI: 10.1111/bjd.12230
Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort
Abstract
Background: There is indication of an increasing prevalence of psoriasis in some western populations. However, the results are not conclusive.
Objectives: To analyse trends in the prevalence of psoriasis over the past 30 years, separating age, birth cohort and time period effects.
Methods: Five population-based surveys in North Norway, the Tromsø Studies 2-6, collected between 1979 and 2008, were studied. Participants aged 20-79 years with self-reported psoriasis data in at least one of the surveys were included, yielding a total of 69,539 observations from 33,387 unique individuals born between 1915 and 1977. Trends in psoriasis prevalence were examined using cross-sectional, time lag and longitudinal designs of graphical plots. Observed trends were further evaluated in generalized linear-regression models.
Results: The self-reported lifetime prevalence of psoriasis increased from 4·8% in 1979-1980 to 11·4% in 2007-2008. Graphical plots showed an increasing prevalence of psoriasis with each consecutive survey in all examined age groups and birth cohorts, leaving time period effects as the explanation for the increase. The odds for psoriasis in the cohort were 2·5 times higher in 2007-2008 than in 1979-1980 (adjusted odds ratio 2·49, 95% confidence interval 2·08-2·99). The prevalence of persons reporting a doctor's diagnosis of psoriasis was 9·9% in the last survey. In subgroups of the study population, psoriasis was associated with higher body mass index, lower physical activity during work and leisure time, lower educational level and smoking.
Conclusions: Our findings indicate an increasing prevalence of self-reported psoriasis. This could represent a true increase in prevalence, possibly due to changes in lifestyle and environmental factors, or an increased awareness of the disease.
© 2013 The Authors. BJD © 2013 British Association of Dermatologists.
Similar articles
-
Prevalence of obesity, central obesity and the associated factors in urban population aged 20-70 years, in the north of Iran: a population-based study and regression approach.Obes Rev. 2007 Jan;8(1):3-10. doi: 10.1111/j.1467-789X.2006.00235.x. Obes Rev. 2007. PMID: 17212790 Review.
-
Psoriasis in Norway as observed in a population-based Norwegian twin panel.Br J Dermatol. 2005 Aug;153(2):346-51. doi: 10.1111/j.1365-2133.2005.06613.x. Br J Dermatol. 2005. PMID: 16086747
-
Prevalence of selected risk behaviors and chronic diseases and conditions-steps communities, United States, 2006-2007.MMWR Surveill Summ. 2010 Sep 24;59(8):1-37. MMWR Surveill Summ. 2010. PMID: 20864923
-
State-specific prevalence of selected chronic disease-related characteristics--Behavioral Risk Factor Surveillance System, 2001.MMWR Surveill Summ. 2003 Aug 22;52(8):1-80. MMWR Surveill Summ. 2003. PMID: 14532868
-
Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender.Br J Dermatol. 2021 Feb;184(2):243-258. doi: 10.1111/bjd.19169. Epub 2020 Jun 21. Br J Dermatol. 2021. PMID: 32358790
Cited by
-
Treatment use and satisfaction among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP).J Eur Acad Dermatol Venereol. 2019 Feb;33(2):340-354. doi: 10.1111/jdv.15252. Epub 2018 Nov 28. J Eur Acad Dermatol Venereol. 2019. PMID: 30242921 Free PMC article.
-
Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations.Therap Adv Gastroenterol. 2022 Jul 28;15:17562848221115312. doi: 10.1177/17562848221115312. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 35924080 Free PMC article. Review.
-
Epidemiology of psoriasis in hard-to-treat body locations: data from the Danish skin cohort.BMC Dermatol. 2020 May 20;20(1):3. doi: 10.1186/s12895-020-00099-7. BMC Dermatol. 2020. PMID: 32434510 Free PMC article.
-
Three-year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trial.J Eur Acad Dermatol Venereol. 2021 Dec;35(12):2398-2408. doi: 10.1111/jdv.17486. Epub 2021 Aug 17. J Eur Acad Dermatol Venereol. 2021. PMID: 34192387 Free PMC article. Clinical Trial.
-
Skin health of community-living older people: a scoping review.Arch Dermatol Res. 2024 Jun 1;316(6):319. doi: 10.1007/s00403-024-03059-0. Arch Dermatol Res. 2024. PMID: 38822889 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous